Literature DB >> 10522662

Topical imiquimod therapy for chronic giant molluscum contagiosum in a patient with advanced human immunodeficiency virus 1 disease.

R Buckley1, K Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10522662     DOI： 10.1001/archderm.135.10.1167

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  6 in total

1.  The MC159 protein from the molluscum contagiosum poxvirus inhibits NF-κB activation by interacting with the IκB kinase complex.

Authors:  Crystal M H Randall; Janet A Jokela; Joanna L Shisler
Journal:  J Immunol       Date:  2012-02-01       Impact factor: 5.422

Review 2.  Topical imiquimod: a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma and other skin lesions.

Authors:  Antona J Wagstaff; Caroline M Perry
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Analysis of cellular and behavioral responses to imiquimod reveals a unique itch pathway in transient receptor potential vanilloid 1 (TRPV1)-expressing neurons.

Authors:  Se-Jeong Kim; Goon Ho Park; Donghoon Kim; Jaekwang Lee; Hyejung Min; Estelle Wall; C Justin Lee; Melvin I Simon; Sung Joong Lee; Sang-Kyou Han
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-07       Impact factor: 11.205

4.  Disseminated molluscum contagiosum in a HIV-positive child. Improvement after therapy with 5% imiquimod.

Authors:  Martin Theiler; Werner Kempf; Katrin Kerl; Lars E French; Günther Fl Hofbauer
Journal:  J Dermatol Case Rep       Date:  2011-06-06

5.  Imiquimod enhances excitability of dorsal root ganglion neurons by inhibiting background (K(2P)) and voltage-gated (K(v)1.1 and K(v)1.2) potassium channels.

Authors:  Jaekwang Lee; Taekeun Kim; Jinpyo Hong; Junsung Woo; Hyunjung Min; Eunmi Hwang; Sung Joong Lee; C Justin Lee
Journal:  Mol Pain       Date:  2012-01-11       Impact factor: 3.395

6.  Seroprevalence of Molluscum contagiosum virus in German and UK populations.

Authors:  Subuhi Sherwani; Laura Farleigh; Nidhi Agarwal; Samantha Loveless; Neil Robertson; Eva Hadaschik; Paul Schnitzler; Joachim Jakob Bugert
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.